Showing results (1-10 of 263) with videos related to
Sort By:
Pageof 27
Current Medicinal Chemistry|April 23, 2002
Docetaxel (taxotere) in the treatment of non-small cell lung cancerVassilis GeorgouliasExpert Review of Anticancer Therapy|September 5, 2017
Risk-reduction and treatment of chemotherapy-induced peripheral neuropathyMarios Bakogeorgos, Vassilis GeorgouliasExpert Opinion on Emerging Drugs|November 3, 2005
Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancerSofia Agelaki, Vassilis GeorgouliasExpert Opinion on Pharmacotherapy|July 1, 2010
Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancerAthanasios Kotsakis, Vassilis GeorgouliasExpert Review of Anticancer Therapy|August 14, 2008
Docetaxel in the treatment of advanced non-small-cell lung cancerEmmanouel Saloustros, Vassilis GeorgouliasLung Cancer (Amsterdam, Netherlands)|October 15, 2011
Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of careAthanasios G Pallis, Vassilis GeorgouliasTherapeutic Advances in Medical Oncology|September 10, 2011
How close are we to customizing chemotherapy in early non-small cell lung cancer?Georgios Ioannidis, Vassilis Georgoulias, John SouglakosWorld Journal of Gastroenterology|March 12, 2010
Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancerZacharenia Saridaki, Vassilis Georgoulias, John SouglakosWorld Journal of Gastroenterology|June 20, 2014
Prognostic and predictive significance of MSI in stages II/III colon cancerZacharenia Saridaki, John Souglakos, Vassilis GeorgouliasExpert Review of Molecular Diagnostics|December 30, 2016
Classifying circulating tumor cells to monitor cancer progressionPanagiota Economopoulou, Vassilis Georgoulias, Athanasios KotsakisPageof 27